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ABSTRACT
Motivation: Proteins of all kinds can self-assemble into highly
ordered β-sheet aggregates known as amyloid ﬁbrils, important
both biologically and clinically. However, the speciﬁc molecular
structure of a ﬁbril can vary dramatically depending on sequence and
environmental conditions, and mutations can drastically alter amyloid
function and pathogenicity. Experimental structure determination has
proven extremely difﬁcult with only a handful of NMR-based models
proposed, suggesting a need for computational methods.
Results: We present AmyloidMutants, a statistical mechanics
approach for de novo prediction and analysis of wild-type and mutant
amyloid structures. Based on the premise of protein mutational
landscapes, AmyloidMutants energetically quantiﬁes the effects of
sequence mutation on ﬁbril conformation and stability. Tested on
non-mutant, full-length amyloid structures with known chemical
shift data, AmyloidMutants offers roughly 2-fold improvement in
prediction accuracy over existing tools. Moreover, AmyloidMutants
is the only method to predict complete super-secondary structures,
enabling accurate discrimination of topologically dissimilar amyloid
conformations that correspond to the same sequence locations.
Applied to mutant prediction, AmyloidMutants identiﬁes a global
conformational switch between Aβ and its highly-toxic ‘Iowa’ mutant
in agreement with a recent experimental model based on partial
chemical shift data. Predictions on mutant, yeast-toxic strains of
HET-s suggest similar alternate folds. When applied to HET-s and
a HET-s mutant with core asparagines replaced by glutamines (both
highly amyloidogenic chemically similar residues abundant in many
amyloids), AmyloidMutants surprisingly predicts a greatly reduced
capacity of the glutamine mutant to form amyloid. We conﬁrm this
ﬁnding by conducting mutagenesis experiments.
Availability: Our tool is publically available on the web at
http://amyloid.csail.mit.edu/.
Contact: lindquist_admin@wi.mit.edu; bab@csail.mit.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Under optimum conditions, proteins with diverse primary sequence
exhibit the ability to self-assemble into structurally varied, but highly
∗To whom correspondence should be addressed.
ordered β-sheet aggregates known as amyloid fibrils (Dobson,
2003). Those forming amyloid under normal physiological
conditions can have profound effects on biological systems—
deleterious and beneficial. On the one hand, amyloids play a role in
diseases such as Alzheimer’s, Parkinson’s and Huntington’s, as well
as systemic amyloidosis. On the other, they serve vital functions
in normal biology such as in human peptide hormone storage,
biofilm formation and a mechanism of protein-only inheritance by
yeast prions (Halfmann and Lindquist, 2010). However, the generic
nature of the fold, the observation that most proteins do not form
amyloid under normal conditions and the ability of many amyloids
to adopt multiple amyloid structures from the same peptide sequence
(structural strains) confounds standard sequence-specific models of
protein folding (Ostapchenko et al., 2010). Moreover, sequences
with only a small likelihood of forming amyloid can remain so given
many mutations, or become abundantly amyloidogenic after only a
single point change (Lie et al., 2004). Therefore, to better understand
the sequence/structure relationship of amyloid fibrils, a meaningful
predictive model is required that describes the relationship between
a given sequence and its mutational neighborhood.
Countless experimental studies have been performed to probe the
molecular mechanism of these enigmatic structures. However, most
methods (developed primarily for globular proteins) are difficult to
apply to amyloids due to their large size and insolubility. Techniques
such as solid-state nuclear magnetic resonance (NMR) spectroscopy
and hydrogen-deuterium exchange (H/D-exchange) have brought
us the most information about fibril structure, but only through
exhaustive work and complex experimental design (Luca et al.,
2007; Lührs et al., 2005; Mukrasch et al., 2009; Vilar et al.,
2007; Wasmer et al., 2008). The high cost of such studies has
prevented the kinds of large-scale investigations that can reveal
the underlying sequence/structure relationships in functional and
pathogenic amyloid folds.
Seminal work has shown that computational prediction of
sequence amyloidogenicity can help guide and speed investigations
of amyloid structure (Alberti et al., 2009; Bryan et al., 2009;
Fernandez-Escamilla et al., 2004; Tartaglia and Vendruscolo
et al., 2008; Trovato et al., 2007). These advances enabled new
possibilities for genome-wide studies, such as the discovery of
19 new functioning amyloid proteins in yeast (Alberti et al.,
2009). More specialized tools (Maurer-Stroh et al., 2010; Thompson
et al., 2006) have been further developed that detail the structure
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of one particular amyloid fibril conformation: ‘steric zippers’, a
repeated, dry β-strand/β-strand packing consisting of a few amino
acids (Sawaya et al., 2007). However, other more elaborate amyloid
conformations such as β-solenoids (Wasmer et al., 2008) cannot be
considered by these specialized methods. Unfortunately, while these
techniques can generate high-resolution structural predictions, they
can only predict structural detail for regions of ∼6 to 10 residues
at a time due to the assumption of a steric zipper conformation.
While such short segments may act as hot spots for amyloid
formation, a full-peptide structure prediction cannot be made, which
encompasses the size of amyloid sequences found in nature. In the
opposite vein, earlier tools are able to predict the amyloidogenicity
of sequences of any length, and agnostic to a particular molecular
conformation, but unfortunately their structural prediction accuracy
can suffer, achieving at best ∼40% sensitivity on per-residue
β-sheet location assignment and can exhibit insensitivity to sequence
mutation (Morel et al., 2006). Moreover, these tools do not predict
complete super-secondary structures, and do not capture the finer
details of β-sheet residue/residue interactions that allow one amyloid
conformation to be distinguished from another.
In this article, we develop an algorithm, AmyloidMutants,
which predicts amyloid fibril structural conformations, and the
sequence mutations that stabilize, reconfigure and de-stabilize
each fibril conformation. Like earlier tools, our approach handles
full-length amyloid sequences, but greatly improves predictive
accuracy by calculating Boltzmann-distributed energetics over
only those β-strand arrangements likely to be found in amyloid
fibrils. A statistical mechanical ensemble is constructed that scores
a complete family of millions of conformational states and
sequence polymorphisms (a ‘mutational landscape’). A comparison
of these sequence/structure states allows for the prediction of
likely conformations and the identification of sequence determinants
of structural heterogeneity. The goal of our algorithm is thus to
efficiently calculate all these possible states, and produce accurate,
physically meaningful amyloid fibril predictions.
AmyloidMutants is sensitive enough to distinguish dramatic
shifts from one amyloid conformation to another when as little
as a single point mutation is made; at the same time, it provides
highly accurate predictions of structure, strain conformations and
mutant amyloidogenicity. Indeed, in agreement with experimental
observations, our tool identifies separate, incompatible amyloid
conformations that are preferentially induced by wild-type (WT)
Aβ and the Aβ Iowa mutant (Tycko et al., 2009), as well as
similarly distinct structures resulting from wild-type and yeast-toxic
mutant strains of HET-s (Couthouis et al., 2009). AmyloidMutants
also allows us to probe the amyloidogenic relationship between
chemically similar residues such as Asn and Gln, which revealed
a specific HET-s sequence sensitivity to Asn.
2 APPROACH
We present AmyloidMutants, a web-based tool for predicting
the structural and mutational landscapes of amyloid fibrils using
an ensemble algorithm. In an ensemble predictor, each peptide
sequence is presumed to fold into a complete set of millions
(or billions) of unique structural states, with a single energetic
value calculated for each state according to its entire conformation
(McCaskill, 1990). From this quantified set of all possible structures,
clusters of low-energy states with similar conformations can be
(a)
(c)
(b)
Fig. 1. Amyloid fibril schemas used for analysis. Amyloid fibril schemas,
diagrammed from side and top perspectives. Red indicates a single fibril
peptide flanked by two gray adjacent peptides along the fibril axis. (a)
Schema P , a 2-sheet β-solenoid with unrestricted number of rungs per
peptide and parallel intra- and interchain interactions. (b) Schema A,
identical to P except with antiparallel interchain interactions. (c) Schema S,
a serpentine cross-β structure with unrestricted number of packed intrachain
β-sheets. All β-strand hydrogen bonds formed interchain.
extracted as predictions of likely real-world structures, with relative
probabilities of occurrence. A mutational ensemble predictor simply
increases the dimensionality of this set by including sequence
variation within each state. (Note, ‘ensemble’ predictors differ from
consensus predictors; the latter produces a single prediction based
on the consensus of multiple authors’ algorithms.)
The definition of an amyloid fibril ‘state’ greatly impacts
the accuracy of an ensemble predictor: including atomic details
would result in an intractable computation, while high-level
representations that work in 1D sequence space can miss important
steric and energetic details. To capture critical 3D elements while
retaining efficiency, we choose to model super-secondary structural
information—each state contains a sequence and a unique set of
residue/residue β-strand backbone interaction pairs. But even so,
calculating the energy of all mathematically possible interactions
would introduce an exponential number of states as a function of
sequence length.
We introduce ‘schemas’ as an algorithmic construct to solve this
by partitioning fibrillar from non-fibrillar conformations, enforcing
steric consistency and enabling energetic calculations over all
amyloid fibril sequence/structure states. For efficiency and usability
purposes, putative amyloid fibril states are separated into three
largely distinct topology families: schemas P , A and S, which to our
knowledge, together subsume the variation found in most published
experimental and hypothetical amyloid fibril structure models
(Fig. 1). These schemas also account for sequence variation through
a simple user specification of the mutational possibilities that should
be explored: e.g. ‘all Val can mutate to Ala, Leu, or Ile’. For example,
schema P and A describes an abstract ‘β-solenoid’ encompassing
millions of structures with unique residue/residue interactions
and varying numbers of β-strands, β-rungs, β-sheet width, coil
location, residue orientation and residue packing neighbors (for
example, HET-s A predictions in Section 4 calculate the energy
of ∼4 billions states). Specific 2-, 3- and 4-sheet β-helix-like
structures are accounted for by the introduction of ‘kinks’ (Fig. 2).
Similarly, schema S represents millions of possible full-length
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Fig. 2. β-strand ‘kinks’extend schemas in Figure 1 to allowAmyloidMutants
to model sharp β-sheet turns like those found in β-solenoids. Kink represents
a deviation in the standard β-sheet in/out residue sidechain orientation.
peptide ‘serpentine’ conformations, putatively containing multiple
steric zipper interfaces.
Conceptually, each schema ‘shape’can be thought to resemble the
‘architecture’ level of CATH (Pearl et al., 2003) protein structure
classification: for example, schema P resembles the ‘2-solenoid’
and ‘3-solenoid’ classifications that make up 2 out of the 20
‘mainly-beta’ architectures in all proteins in CATH. We note
that schemas should not be confused with threading templates
used in other protein and amyloid modeling tools (Thompson
et al., 2006): threading tools fix a peptide backbone to a specific
atomistic position and computationally score the effects of residue-
specific side chains, whereas schemas cover a wide range of
amyloid conformation and peptide backbone arrangements in
3D space. Further, AmyloidMutants does not predict kinetics of
amyloid formation, but simply the set of possible conformations
at steady-state encompassing arbitrary environment conditions.
No restrictions are placed on the location or size of structural
elements with the exception of individual β-strand lengths, which is
fixed to a range of 6–12 residues for efficiency purposes, and can
vary within a single structure (except when noted in Section 1 of
Supplementary Material).
3 METHODS
3.1 Calculating amyloid ensembles
AmyloidMutants models the structural effects of sequence variation by
conceptually scoring all possible amyloid fibril conformations that any
sequence (and its mutants) can attain. Using a statistical mechanical
approach, all structures are members of a canonical ensemble, with each
state’s energetic value assigned according to a Boltzmann distribution. Such
an ensemble predictor differs fundamentally from existing techniques that
perform an algorithmic search for an individual, lowest energy structure
state. However, computing the score of all possible states in atomistic detail is
considered computationally intractable (Istrail, 2000), so our approach uses a
philosophy of domain restriction (via schemas) to efficiently predict accurate,
physically meaningful amyloid structures at the level of super-secondary
structure. The utility of such an approach has been demonstrated in RNA
(McCaskill, 1990; Waldispühl et al., 2008b); however, protein structures are
too complex to tractably apply their same methods.
At the core of our framework lies the ability to compute the
Boltzmann partition function (Z) for given protein sequences. This
thermodynamic normalization constant encodes the statistical variation
of a system in equilibrium, and is used to identify the significance
of structures within an ensemble. Z is defined by the sum: ∀s, Z =∑
s e
−Es/R T
, given temperature T , the physical constant R and a
Boltzmann-distributed energy score Es for every conformation s within the
ensemble. AmyloidMutants extends the notion of a structural ensembles
to analyze protein sequence/structure ensembles, redefining the partition
function Z as: ∀ω, ∀s, Z =∑ω
∑
s e
−Es/R T, given sequences ω and
structures s. This encodes statistical variations in protein structure as
well as sequence, distributed according to the energetic likelihood of that
sequence’s conformations. With this, one can identify energetically favorable
sequence/structure assignments and quantitatively measure the energetic
difference of between states.
AmyloidMutants is implemented using C++, with modular templates
describing the recursively enumerable sequence and structure space. An
analysis is performed on the sequence input to optimize the search
across sequence/structure states, and a dynamic programming procedure
is constructed that traverses and scores all possible states, tabulating these
values. From this, Z can be calculated via a simple traversal.
3.2 Amyloid schema definition
Schemas are generative rules restricting the exponential set of peptide
conformations to only those that form amyloid fibrils. These are defined in
two parts, a recursive encoding of structure space and a protocol giving a list
of all allowed sequence mutations. To model a theoretically endless fibril we
employ a concept of symmetry, representing an amyloid as the conformation
of single peptide combined with two sets of inter-peptide β-sheet interactions
up and down the axis. We detail here specific characteristics used to define
a schema, beyond the qualitative description in Figure 1.
Structure space is defined as putative geometric arrangement of β-sheets at
the resolution of (i) intrapeptide hydrogen bonds along the fibril axis; (ii) β-
sheet/β-sheet packing perpendicular to the axis (e.g. steric-zipper packings,
etc.); and (iii) peptide/peptide symmetry describing interpeptide hydrogen
bonds. Residue side chain orientations are also included in the model to
indicate inward (hydrophobically packed) and outward (solvent exposed)
states. Thus, a single structure can tell you whether a residue is in a β-
sheet or coil, its orientation, which other residue(s) it forms a hydrogen
bonding pair with and which topologically specific β-sheet its found in,
indicating other β-sheets it may pack against. Finally, β-strand ‘kinks’ model
two successive β-strand residues that have the same side-chain orientation
(Fig. 2). Modeling kinks allows more precise energetic parameters when
two sequentially adjacent β-strands form a sharp turn (as in many β-helices),
since these junctions differ from coil-separated β-strands.
Sequence space is defined by a set of allowed mutations off a base
sequence, per sequence position, per residue. For example, ‘position index
10 can either be Ala, Leu, or Val,’ input via programmable macros. This
level of specification is required to avoid an exponential computation, as
there are 20N residue permutations in a sequence of length N . At runtime,
an analysis is performed to determine the minimum dynamic programming
table dimension required to fit each possible mutation. Presently, deletion
and insertion mutations are not supported due to limitations of the energy
models.
Although not used for results in this article, schemas can be further refined
to incorporate specific point knowledge into the ensemble, enabling a more
profitable, iterative back-and-forth between predictions and experimentation.
These refinements include: (i) limiting β-strand or coil length; (ii) enabling
or disabling β-sheet ‘kinks’; (iii) requiring a minimum/maximum total-
fibril β-sheet concentration; (iv) enabling or disabling fibril twist; (v)
permitting N- and C-terminal coil asymmetries; and (vi) allowing user-
defined residue/residue hydrogen bond contacts to be fixed.
3.3 Energy model for amyloid-like interaction
AmyloidMutants uses a potential energy scoring function derived from
observing the frequency of specific residue/residue interactions in (non-
sequence-homologous) PDB (Berman et al., 2000) protein structures. Many
protein and RNA modeling tools (Bradley et al., 2001; Trovato et al., 2007;
Waldispühl et al., 2008a; Zuker and Stiegler, 1981) have successfully used
such statistical potentials because of two main advantages: (i) residue/residue
interactions (or base pairs in RNA) can efficiently capture the important,
energetically stabilizing features of 3D structure without the need of
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molecular detail, and (ii) constructing an energetic scoring function from
known PDB structures does not require a priori expert information, so as
new structures are solved, typically accuracy increases. Note, such statistical
potentials do not incorporate environmental conditions such as pH.
Traditional pairwise contact models calculate the frequency with which
residues pair within a β-sheet (Bradley et al., 2001; Waldispühl et al.,
2006). AmyloidMutants extends this by conditioning each probability by the
local 3D environment, including amphipathicity and solvent accessibility,
β-strand edge proximity, residue-stacking ladders, β-sheet edges and β-sheet
twist [e.g. p(i|j,env)], discretizing higher resolution information important
to amyloid structure. Accordingly, each residue position in every possible
ensemble state has an associated environment that allows the search
procedure to apply the correct energy. For example, residues/residue pairs
facing toward the center of the β-solenoid in schemas P and A would be
considered solvent inaccessible. These β-sheet potentials are combined and
scaled with potentials for consecutive coil residues (p(i,j)), as well as an
optional hydropathic packing score describing the propensity for β-sheet
faces to pack against one another (Kyte and Doolittle, 1982). There is no
explicit cost for the act of mutation, merely an energetic change due to a new
sequence (Section 3 of Supplementary Material). The algorithm supports
additional types of potentials, such as position-specific scoring matrices,
stacked residue-pairs (Waldispühl et al., 2008a), and chemical propensities
(Miyazawa and Jernigan, 1985), although these are not used here.
Formally, a fibril’s energy is decomposed into independent substructure
energy scores that recombine according to the schema topology. The energy
of each state s is defined to be Es =−RTlog(ps)−RTlog(Z), and we make the
assumption that Es can be linearly decomposed into i parts such that Es =∑
i−RTlog(psi )−RTlog(Z) (Clote and Backofen, 2000). The probability
psk thus represents the likelihood of observing a substructural state k, such
as the propensity for two residues to pair within a β-sheet, and log(Z) serves
as a statistical centering constant. Predicted states represent steady-state
conditions and do not reflect folding kinetics.
3.4 Sampling and stochastic contact maps
The principal output of AmyloidMutants is a sampled set of unique
sequence/structure states (a list of sequences and their corresponding
conformations) that is statistically representative of the full ensemble. Prior
work has demonstrated the higher predictive accuracy of ensemble sampling
over minimum energy structures (Waldispühl et al., 2008a). To achieve
this, a sampling procedure performs an energetically weighted stochastic
backtrack over subsequence/substructure scores generated when computing
Z . Populations of similar structures are separated via PAM clustering,
taking as input the number of clusters, and using a distance metric that
optionally combines sequence, secondary structure, energy score, hydrogen
bond registration, coil location and β-strand overlap. A mediod is selected
to represent each cluster. User-definable distance metric changes allow for
independent analysis of specific structural or sequential features.
Another form of output, the stochastic contact map, describes the
Boltzmann-weighted likelihood pi,j that any two residues i and j will form a β-
sheet hydrogen bond, given all the conformations in the ensemble. To remove
schema bias, the null hypothesis probability of any residue i and j forming
a bond is subtracted from pi,j (Section 3 of Supplementary Material). This
allows AmyloidMutants to identify small β-strand interaction motifs within
the ensemble that may be hard to discern from full conformation sampling.
Furthermore, contact maps scores can be used to predict structural properties
such as X-ray crystallography B-values (Waldispühl et al., 2008a).
4 RESULTS
4.1 Secondary and super-secondary structure
prediction
Even in the absence of mutation predictions, AmyloidMutants offers
the the highest structure prediction accuracy to date. We demonstrate
Table 1. Summary of secondary-structure prediction results
Aβ HET-s Amylin α-syn Tau
Sequence length 42 73 37 140 441
Correct β-regions 2 of 2 4 of 4 3 of 3 5 of 5 7 of 8
False-positive β-regions 0 0 0 2 2
Percent sensitive/specificity 100/100 95/95 70/91 81/95 68/95
SOV measure 100 90 97 62 62
this by comparing predictions against experimental data for five
of the best studied WT amyloid proteins: Aβ (Lührs et al., 2005;
Petkova et al., 2003) (39-42aa), HET-s (Wasmer et al., 2008)
(73aa), amylin (Kajava et al., 2005; Luca et al., 2007) (37aa),
α-synuclein (Heise et al., 2005; Vilar et al., 2007) (140aa) and
tau (Mukrasch et al., 2009; von Bergan et al., 2000) (htau40,
441aa). This set covers pathogenic and functional amyloids found
in nature for which there are a number of published structural
experiments, including NMR secondary structure chemical shift
and H/D exchange data. The ability to accurately predict the
structure of such peptides could potentially help elucidate how
native amyloid-related processes (such as biofilm formation) impact
cellular function, and allow for targeted experimentation.
For these five proteins, AmyloidMutants correctly identifies
experimentally observed β-sheet regions in 21 of 22 cases
(Fig. 4, Table 1)—a per-residue secondary-structure classification
sensitivity/specificity of 82%/95% and an average SOV score
of 82 (Zelma et al., 1999). Using the same comparison, the
best of the available full-length amyloid prediction tools (Bryan
et al., 2009; Fernandez-Escamilla et al., 2004; Maurer-Stroh et al.,
2010; Tartaglia and Vendruscolo et al., 2008; Trovato et al.,
2007) produced a classification sensitivity/specificity of 42%/90%
(Zyggregator) (Fig. 3). Per-residue β-sheet classification is used
for this comparison since it can be inferred as a common output
of all tools; however, AmyloidMutants can provide more rich
predictions including super-secondary residue/residue interactions.
Therefore, a detailed analysis of each protein’s predictions is given to
demonstrate these added benefits, along with a demonstration of how
ensemble predictions can help identify alternate fibril conformations
in agreement with published experimental data.
AmyloidMutants was run on each sequence for all three schemas
P , A and S, with the schema that agreed best presented.
An ensemble was calculated, and conformations were sampled
and clustered, with the mediod structures reported (Section 1
of Supplementary Material). Although rough computational tests
can be applied to evaluate the schema fitness (Section 3 of
Supplementary Material), in a typical real-world scenario (and what
has been applied thus far), an uncharacterized amyloid sequence
is predicted using all schemas, and results are compared against
the body of existing experimental data or used to guide further
disambiguating experimentation.
Note, although atomic-resolution steric zipper structures have
been solved for many short (∼4 to 10aa) synthetic peptides (Maurer-
Stroh et al., 2010; Sawaya et al., 2007), AmyloidMutants predictions
on such short peptides are trivial. Schemas can predict the position
and arrangement of steric zipper sites throughout a full-length
peptide, but are not designed to distinguish side-chain rotamers (and
are unrelated to steric zipper classes).
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Fig. 3. AmyloidMutants per-residue β-strand assignments indicate amyloid
core regions, comparable with existing per-residue amyloidogenicity
predictors. AmyloidMutants predictions (green) outperform those tools
available for testing when using their default settings and thresholds.
BETASCAN (gold) (Bryan et al., 2009), ZYGGREGATOR (blue) (Tartaglia
and Vendruscolo et al., 2008), TANGO (cyan) (Fernandez-Escamilla et al.,
2004), PASTA (red) (Trovato et al., 2007) and Waltz (purple) (Maurer-
Stroh et al., 2010), when compared against experimental structure models
supported by NMR, H/D-exchange and mutational analysis (black) (Luca
et al., 2007; Lührs et al., 2005; Mukrasch et al., 2009; Vilar et al., 2007;
Wasmer et al., 2008, 2010). Note, the BETASCAN, ZYGGREGATOR,
TANGO and PASTA tools most closely match our tool’s ability to predict
full-length per-residue amyloidogenicity, whereas Waltz aims to predict short
hots pots that could specifically adopt a steric zipper.
Amyloid Beta (Aβ): an ensemble analysis of Aβ is particularly
poignant as it has many known isoforms (Aβ1-40, Aβ1-42,
Aβ1-40/D23N, Aβ1-40/E22Q, etc.) and subsequences (Aβ16-22,
Aβ11-25, etc.) that have been reported to form a diverse range of
fibril structures, including strain polymorphisms within the same
sequence (Petkova et al., 2005). Our tool predicts the experimentally
observed structure of two possible Aβ conformations, recapitulating
two distinct experimental models of the peptide based on NMR,
H/D-exchange and mutational analysis (Lührs et al., 2005; Petkova
et al., 2003).After clustering, the highest likelihood mediod structure
nearly identically matches the latter of these two models (Lührs
et al., 2005) (Fig. 4a), including β-strand positions, interior/exterior
side chain orientation and the inter peptide parallel hydrogen
bonding registration. This cluster accounts for 55% of the ensemble.
Interestingly, the second highest likelihood mediod exhibits a clear
shift in one of the β-strand regions and aligns very closely with
the earlier NMR model (Petkova et al., 2003). This cluster is more
heterogeneous, including many other structural arrangements, and
accounts for 39% of the ensemble. Furthermore, recent experimental
studies of Aβ conformational variation have shown that fibrils
formed under quiescence and agitation differ, for instance, in the
assignment of position 15 to β-strand (Petkova et al., 2005). The
predicted clusters also make this rough distinction: the larger cluster
does not contain a β-strand at position 15, while the smaller does.
Moreover, brain-seeded fibrils have exhibited spatial proximity
between residues F19/I31, whereas unseeded in vitro fibrils do
not (Paravastu et al., 2009). AmyloidMutants also predicts such a
divergence: in 16% of the ensemble, F19 and I31 are both oriented
toward the center of the fibril, enabling proximal contact. Section 1
of Supplementary Material provides further detail.
HET-s: the 73 amino acid Podospora anserina HET-s prion is
the most complex amyloid whose atomic-level 3D structure has
been solved (Wasmer et al., 2008), forming a well-ordered β-
helix with two rungs per chain and four β-sheets that are more
appropriately modeled as two pairs of β-sheets separated by a
kink in the standard ‘in/out’ residue orientation. AmyloidMutants
strongly predicts two possible structures, the most likely of which
forms a two-rung β-solenoid that almost exactly mirrors the NMR
model, including hydrogen bond registration, side chain orientation
and kink location (Fig. 4b, accounting for 68% of the ensemble).
The lower likelihood conformation incorporates only a single rung,
matching one of the rungs in the NMR structure. This strong
predictive bias toward only two possible structures may relate to the
observed conformational homogeneity of HET-s fibrils. Achieving
such high accuracy on this difficult β-structural topology supports
our tool’s use for mutational analysis across broadly different
fibril types. Furthermore, recent experimental studies have partially
characterized a distant homologue to P.anserina HET-s found in
Fusarium graminearum (Wasmer et al., 2010). Although FgHET-s
exhibits only 38% sequence similarity, solid-state NMR and H/D-
exchange data suggest an extremely similar β-solenoidal structure
as in PaHET-s. Despite the large difference in sequence, predictions
very well match the FgHET-s structural model, aligning β-strand
location, hydrogen-bond registration, side-chain orientation and
kink location (Supplemantary Fig. S1).
Amylin: AmyloidMutants predictions for human amylin indicate
two viable conformations: a 2-sheet β-solenoid forms 80% of
the ensemble and agrees closely with NMR and microscopy
results (Luca et al., 2007) (Fig. 4c); and a much less likely three-
sheet serpentine model that aligns almost perfectly with an older
model of amylin structure (Kajava et al., 2005). Interestingly, the
experimental model identifies an interprotofibril interaction between
Phe23 and Tyr37—something beyond the scope of our schema.
However, our β-solenoid predictions clearly separate into two
distinct populations, one incorporating Phe23 into a β-sheet and
one that does not. This highlights the importance of an ensemble
analysis: the existence of high-likelihood alternate structures may
draw attention to an overlooked structural interaction.
α-Synuclein: five β-sheet regions in α-synuclein have been
identified through substantial experimental effort (Heise et al.,
2005; Vilar et al., 2007). AmyloidMutants ensemble predictions
agree extremely well with these results, aligning all five β-sheet
regions, and identifying other important experimental observations
such as a β-sheet break around residues 67–68 (Fig. 4d). One
of the predicted clusters does produce a false positive, however,
identifying amphipathic β-strands in the N-terminal region, a
disordered segment thought to favor a lipid-binding amphipathic
α-helical structure (Section 1 of Supplementary Material).
Tau (τ): NMR studies have shown this 441 amino acid long amyloid
to form a mixture of up to eight transient β-sheet regions (Mukrasch
et al., 2009), with two specific β-strands necessary for fibril
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(a)
(c) (b)
(d)
(e)
Fig. 4. AmyloidMutants structure predictions match experimentally observed β-strand interactions of Aβ1-42 (a), HET-s (b), amylin (c), α-synuclein (d) and
tau (e). (a) Diagram depicts Aβ1-42 β-strand in gray, residues in blue (with in/out orientation) and β-sheet/β-sheet packing as one β-strand above another, packed
residues facing center. Predicted structure (green arrows) mirrors NMR structure (Lührs et al., 2005) (black arrows), including most packing orientations.
Predicted kink occurs because schema does not account for known D23/K28 salt bridge. (b) Similar depiction of HET-s prediction (top, green arrows)
compared with NMR model (Wasmer et al., 2008) (bottom, black arrows) shows near identical match, including residue orientations and kink location. (c)
Top two amylin predictions (solid, striped green arrows) align well to NMR model (Luca et al., 2007) (black arrows). Predictions differ only by their inclusion
of Phe23 (∗) within β-sheet, a residue experimentally shown to form non-β-sheet interpeptide interactions not considered by schema. (d) Top two α-synuclein
predictions (i,ii) agree very well with H/D exchange data (iii,iv) and NMR model (v) (Heise et al., 2005; Vilar et al., 2007). (e) Tau predictions identify
7/8 β-regions observed experimentally (Mukrasch et al., 2009). The highest AmyloidMutants scores (red boxes) specifically identify regions 274–279 and
305–310, positions believed crucial to fibril nucleation (von Bergan et al., 2000).
assembly (von Bergan et al., 2000) (positions 306–311 and 275–
280). Predicted β-sheets align very closely with these observed
regions in seven of eight cases. Moreover, AmyloidMutants
identifies the two hexapeptides experimentally observed necessary
for assembly by predicting their β-strand interactions as having
the strongest score (Section 1 of Supplementary Material). Four
false positive regions are predicted to contain β-strands, although
similar to α-synuclein, two overlap with observed α-helices which
the schema does not incorporate and may contain sequences with
high β-sheet propensity. Overall, the sensitivity and specificity of
our predictions over such a long sequence considerably advance the
state of the art (Fig. 3).
4.2 Prediction of a conformational switch in Aβ and
HET-s mutants
AmyloidMutants is uniquely capable of identifying change in
amyloid fibril conformation from one amyloid β-sheet topology
to another. This distinction from tools that predict general
amyloidogenicity is important as a structural change from one
amyloid form to another can have a dramatic impact on
oligomerization and nucleation rates (Kim and Hecht, 2008), disease
infectivity (Tycko et al., 2009), and prion propagation (Alberti et al.,
2009). We have used this ability to identify potential alternate,
distinct amyloid fibril conformations that arise in the Aβ familial
‘Iowa’ mutation (Tycko et al., 2009) and yeast-toxic mutants of
HET-s (Berthelot et al., 2009; Couthouis et al., 2009) (details and
comment provided in Sections 2 and 3 of Supplementary Material).
Described below are these AmyloidMutants results, highlighting
consistencies with published experimental data.
Aβ Iowa mutant: recent studies (Tycko et al., 2009) suggest that
Aβ1-40/D23N may form an antiparallel β-strand fibril conformation
that differs completely from known experimental models (Lührs
et al., 2005; Petkova et al., 2003). This work suggests an antiparallel
β-sheet around residues 16–22 (with unknown length), with an
interβ-strand interface such that L17 bonds to A21 [designated
‘17+k↔21-k’ registry (Tycko et al., 2009)]. Similarly, a second
antiparallel β-sheet likely exists around positions 30–36, with
L34 and F19 in close contact. Interestingly, this specific Aβ1–40
registry has only previously been seen in the peptide fragment
Aβ16–22, which lacks D23 (Tycko and Ishii, 2003), while the
antiparallel forming fragment Aβ11–25 shows inverted ‘17+k↔22-k’
and ‘17+k↔20-k’ registries (Petkova et al., 2004) (Table 2).
To analyze this point mutant, we predicted ensembles for Aβ1–40
and Aβ1–40/D23N using schema A (which allows antiparallel
inter-peptide interactions). Detailed in Table 2, AmyloidMutants’
Aβ1–40/D23N predictions strongly preferred a ‘17+k↔21-k’ registry
conformation, with predicted contacts between L34/F19, and very
little variation within the ensemble. This arrangement agrees
with observed Aβ16–22 structures. Conversely, predictions for
WT Aβ1–40 are quite heterogeneous, although with the largest
cluster of structures forming ‘17+k↔22-k’ registry, in agreement
with observed Aβ11–25 structure. More strikingly, the ‘17+k↔21-
k’ registry conformation favored by Aβ1–40/D23N appears to be
strongly disfavored by Aβ1–40 (and Aβ1–40/D23N appears to disfavor
‘17+k↔22-k’ registry). These predictions and the divergence in
ensemble makeup between Aβ1–40 and Aβ1–40/D23N strongly
supports the idea that the D23N mutation results in a singular
energetically favorable conformational rearrangement from parallel
β-sheets (in WT) to antiparallel β-sheets (in the D23N mutation). At
the residue level, the adoption of this ‘17+k↔21-k’ conformation
may be driven by both the alignment of oppositely charged K16 and
E22 and the stacking arrangement of Q15 and N23 (Table 2).
HET-s yeast-toxic mutants: our technique is able to further
predict putative conformational rearrangements between a set of
HET-s mutants shown to exhibit toxicity in yeast. In recent
studies (Berthelot et al., 2009; Couthouis et al., 2009), structural
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Table 2. AmyloidMutants predictions reveal conformational switch between
Aβ1–40 and Aβ1–40/D23N in agreement with published data
‘17+k↔22-k’ ‘17+k↔21-k’ Other
Aβ1–40 registry
QKLVFFAEXV||||||||||
VXEAFFVLKQ
QKLVFFAEX|||||||||
XEAFFVLKQ
Pred. Aβ1–40(%) 69 6 25
Pred. Aβ1–40/D23N(%) 11 52 37
Obs. Aβ11–25  – –
Obs. Aβ16–22 –  –
Predictions show a significant change in the conformational landscapes of Aβ1–40 and
Aβ1–40/D23N in agreement with published experimental evidence (Tycko et al., 2009)
of an antiparallel, ‘17+k↔21-k’ registry β-sheet in Aβ1–40/D23N (boldface). Sampled
ensemble structures were classified into one of three categories of β-sheet registry, with
the percent makeup of each provided. β-sheet registry is classified by residue/residue
pairing, depicted with X highlighting position 23. Check marks indicate experimentally
observed registrations in Aβ11–25 (Petkova et al., 2004) and Aβ16–22 (Tycko and Ishii,
2003).
differences were found in a toxic HET-s mutant (named m8) and
compared against four other non-toxic mutants (m3, m4, m9, m11)
and WT. Notably, m8 exhibits a marked change from WT in
secondary structure makeup, showing a shift of approximately half
of the β-strand structure from parallel to antiparallel interactions.
AmyloidMutants can distinguish these phenotypically different
mutants by inspecting predicted results using different schemas and
comparing the relative structural heterogeneity of the ensembles. We
premise that sequence mutants which significantly alter the predicted
ensemble makeup (away from WT) are more likely to exhibit
a different high-level conformational arrangement, and that high-
likelihood conformations within an ensemble offer good predictive
fits. Conversely, predictions that do not particularly favor any single
conformation may suggest a poor fit. Table 3 reports ensemble
predictions for the given six mutants, comparing schemas P and
A. Across all mutants, schema P predict clusters of 2-rung and 1-
rung structures, while schema A predicts three clusters: two forms
of 2-rung solenoids and one with 1-rung (Supplementary Fig. S11).
The difference between schemas P 2-rung and A 2-rung
correlates with the shift in secondary structure makeup observed —
P 2-rung contains only parallel β-sheet structures while A 2-rung
can contain an equal amount of parallel and antiparallel β-sheet
structure. Under schema P , we see that WT, m4, and m8 form
better 2-rung solenoids than a 1-rung solenoid, whereas with m3,
m9, and m11, the opposite is true or no preference is apparent. This
discrimination of mutants based on the structural landscape mirrors
phenotypic variation seen by GFP-tagged aggregates (Couthouis
et al., 2009) (independent of predictive accuracy). Under schema A,
we see similarities between the structural distribution of WT, m4,
m3, m9, and m11; however, the toxic m8 mutant appears to strongly
prefer only one of the 2-rung conformations. Such a dramatic shift
in the predicted ensemble could suggest that the m8 mutant is
energetically inclined to form the structure in cluster A 2-rung-A.
4.3 Identification of preferential Asn amyloidogenicity
over Gln in HET-s
Beyond its ability to discriminate amyloid fibril structure states,
AmyloidMutants accurately models more coarse amyloidogenicity
Table 3. AmyloidMutants ensemble predictions of HET-s sequence variants
reveal the yeast-toxic mutant m8 to be unique
Schema/class. WT m4 m8 m3 m9 m11
P 2-rung (%) 75 95 72 13 49 55
P 1-rung (%) 25 5 28 87 51 45
A 2-rung-A (%) 45 42 81 44 56 50
A 2-rung-B (%) 25 43 0 36 22 40
A 1-rung (%) 30 15 19 20 22 10
Aggregation Ring Foci Foci diff. diff. diff.
Toxicity − Minor Severe − − −
Ensemble conformational landscape predictions of six HET-s variants produced two
general structure classifications for schema P and three general classifications for
schema A (rows, relative percent makeup given). While other mutants do not favor one
particular schema A structure, the yeast-toxic mutant m8 exhibits a strong energetic
bias for A 2-rung-A. The differences in structure bias shown may suggest an increased
likelihood that m8 adopts an antiparallel conformation (boldface). Observed phenotypic
differences between mutants are summarized at the bottom (Couthouis et al., 2009).
properties, allowing us to study a more fundamental question:
the role chemically similar residues Asn and Gln play in fibril
structure. Given the high propensity of Q/N-rich peptides to form
amyloid (Chiti and Dobson, 2006), the amyloidogenic potential
of Asn and Gln has often been considered equal—however,
recent evidence suggests that N-rich proteins may have a slightly
higher tendency to form amyloid (Alberti et al., 2009) [even
though Gln mutations can improve stability (Gromiha et al.,
1999)]. We study this question by considering the effect of four
ladder-forming asparagine residues in P.anserina HET-s (positions
226, 243, 262 and 279) which are believed important for fibril
stabilization (Wasmer et al., 2008), and whose regions are conserved
in a F.graminearum homolog. AmyloidMutants sequence/structure
landscapes were calculated permitting these four residues to mutate
to Gln (‘HET-s/4N→Q’), and the likelihood and corresponding
energetic weight of each sequence within the ensemble was
compared. The WT HET-s sequence was much more energetically
favorable than HET-s/4N→Q, comprising ∼96% of the ensemble,
suggesting a greatly reduced ability of HET-s/4N→Q to form fibrils,
and a putatively higher amyloidogenic potential of Asn over Gln.
Stochastic contact map predictions further illustrate this difference
between sequences (Supplementary Fig. S9).
We tested these predictions experimentally, using purified
recombinant WT and 4N→Q HET-s proteins (Section 4 of
Supplementary Material). Denatured proteins were diluted into a
physiological buffer and allowed to form amyloid. While the WT
protein readily did so, as detected by the retention of detergent-
insoluble aggregates on a non-binding membrane, the mutant protein
was recalcitrant to amyloid formation (Fig. 5).
4.4 Mutational landscapes predict experimental
amyloidogenicity
AmyloidMutants’ ability to accurately predict amyloidogenicity
is validated by comparing our results against a large number of
experimentally characterized amyloid mutants. This includes an
analysis of the 289-residue HET-s/HET-S natural homologs found
in P.anserina, a combination of three Aβ scanning mutagenesis
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Fig. 5. HET-s/4N→Q is defective for amyloid assembly. Purified proteins
were filtered through a non-binding membrane either before or after
incubation for 24 h in a physiological buffer. Protein aggregates that formed
during the incubation are retained on the surface of the membrane, as
visualized by Ponceau-S staining.
studies, and a set of 74 synthetic mutants of Aβ created by random
mutagenesis. The amyloidogenicity of each mutation is predicted
by computing a joint mutational landscape over WT and mutant
sequences, and quantifying which sequence more readily forms
amyloid according to its energetic weight within the ensemble.
For example, if WT sequence/structure states occupy 90% of the
ensemble, then any specified mutations are likely to result in a less
amyloidogenic peptide (Supplementary Text Section 3).
HET-s/HET-S: In P.anserina, the HET-s allele forms an amyloid
conformation in its prion form, while the HET-S allele does not,
despite differing by only three residues in the amyloid-forming 72-
residue C-terminus, and 13 overall (Coustou et al., 1999). Predicting
the joint HET-s/HET-S mutational landscape, AmyloidMutants
found that ∼72% of the ensemble favored HET-s, indicating that it
is more amyloidogenic than HET-S. Although N-terminal mutations
can induce a prion state in HET-S (Coustou et al., 1999), our
predictions suggests a sequence bias in HET-s permitting a more
energetically favorable path for amyloid formation.
Aβ single-point proline mutagenesis: scanning mutagenesis studies
have been performed on Aβ40 to detect the sequence position effect
of proline-, alanine- and cysteine-replacement on amyloid fibril
formation, measured by WT/mutant G (Shivaprasad et al., 2006;
Williams et al., 2004, 2006). Although P, A and C-replacement G
values are difficult to interpret independently [due to experimental
structural heterogeneity (Williams et al., 2006)], they support the
broader conclusion that Aβ40 positions 18–21, 25–26 and 32–33
are particularly sensitive to P-replacement (Williams et al., 2006).
AmyloidMutants’ predictions of the joint mutational landscape
for individual proline replacements identified positions 16–25 and
31–35 as particularly disruptive in agreement with these studies.
Supplementary Figure S12 plots this agreement along with similar
predictions by TANGO and Zyggregator, although a direct one-to-
one comparison between predictions and G values would be
inappropriate.
Aβmultiple-residue mutagenesis: AmyloidMutants predictions were
also performed on a set of 74 Aβ mutants (Kim and Hecht,
2006, 2008; Wurth et al., 2002) whose relative aggregation levels
were observed by GFP fluorescence relative to WT.AmyloidMutants
accurately identifies which mutants form amyloid more (or less)
readily than WT in 81% of sequences (60 of 74, Supplementary
Fig. S8). AmyloidMutants’ performance on such a large set further
supports its general applicability.
5 DISCUSSION
AmyloidMutants provides the highest accuracy prediction to date
of the full fibril structure of amyloid sequences, but its greater
value is its unique ability to discover which mutations effect a
change in amyloid structure(s), to predict what that structure is
and to assign meaningful energetic weights comparing mutant
conformations. This accuracy is due, in part, to the ability
to model coarse, higher dimension spatial interactions, beyond
simpler 1D sequence motifs. This is an important distinction from
amyloidogenicity predictors that identify structurally homogeneous
peptide sequences (Maurer-Stroh et al., 2010). While the latter can
be helpful during an initial screen (searching for amyloid steric
zippers in particular), AmyloidMutants can predict and provide
insight into the full-length structure (Fig. 3) and residue/residue
interactions of both β-solenoidal and serpentine steric zipper fibrils
(Fig. 1), putatively identifying interactions critical to function or
pathogenicity. Further, through the use of Boltzmann ensembles,
our model of sequence/structure space is the only amyloid modeling
tool that captures fibril structure variation and β-contact structural
topology changes that may arise in in vivo.
The exploration of mutational landscapes is an important
step in understanding differences between amyloid topologies,
how mutational variants arise in the wild, and to elucidate
evolutionary relationships between related amyloid proteins. This
capability depends on AmyloidMutants’ novel thermodynamic
characterization of all points within a mutational landscape, and is
necessary for the discovery of non-additive functional relationships
between sequences and conformational epistasis (Ortlund et al.,
2007). Further, we note that our tool provides additional features
for experimentalists (not used in this article) that allows extra-
sequential experimental data to be incorporated into the predictor
(Supplementary Text Section 1)—as much or as little a priori
knowledge as desired, enabling a new tactic for iterative tool re-use.
At face value, the ability of most proteins to form a
characteristic cross-β-sheet amyloid structure in vitro (Dobson,
2003) seems at odds with the relatively small number of
amyloid-forming proteins that have been identified in vivo,
and the apparently high sequence dependence some amyloids
show when compared against sequence homologs. Moreover, the
existence of both beneficial functional amyloid sequences, and
putatively pathogenic ‘misfolded’ amyloid proteins suggests a
more complicated sequence/structure relationship than is found in
standard protein folding models. The power to accurately predict
amyloid structure from sequence, and to fully characterize the
amyloidogenicity of an entire mutational landscape provides insight
into this problem by identifying recurring sequence motifs, coarse
3D residue arrangements and putative mutational pathways linking
the sequences of known amyloid structures. The immediate impact
of this could improve our ability to identify amyloid structures from
genomic data alone, to better understand familial mutations that
intensify pathogenesis in diseases such as Alzheimer’s, to predict
the interaction strength of fibril regions that may be involved in
nucleation and to enable targeted peptide design to alter fibril
structure or inhibit fibril formation.
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